Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed and Recurrent Glioblastoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchLooking for participantsNCT06072586
What this trial is testing

BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions

Who this might be right for
High Grade GliomaGlioblastoma
St. Joseph's Hospital and Medical Center, Phoenix 82
Testing effectiveness (Phase 2)Ended earlyNCT01898273
What this trial is testing

Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Cellectar Biosciences, Inc. 7
Early research (Phase 1)Looking for participantsNCT07089641
What this trial is testing

ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial

Who this might be right for
GlioblastomaGlioblastoma, IDH-WildtypeGliosarcoma+3 more
Jonsson Comprehensive Cancer Center 50
Very early researchStudy completedNCT04614909
What this trial is testing

Study of Pamiparib in Newly Diagnosed and rGBM

Who this might be right for
GlioblastomaGlioblastoma MultiformeGlioblastoma Multiforme, Adult
Nader Sanai 50
Testing effectiveness (Phase 2)Ended earlyNCT00021229
What this trial is testing

Imatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI) 85
Testing effectiveness (Phase 2)Study completedNCT00445965
What this trial is testing

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more
Memorial Sloan Kettering Cancer Center 78
Early research (Phase 1)Not Yet RecruitingNCT06946680
What this trial is testing

IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Newly Diagnosed and Recurrent Pediatric High-grade Glioma (pHGG) and Newly Diagnosed Diffuse Intrinsic Pontine Glioma (ndDIPG)

Who this might be right for
High-grade GliomaDiffuse Intrinsic Pontine Glioma
University of Florida 24
Testing effectiveness (Phase 2)Looking for participantsNCT05084430
What this trial is testing

Study of Pembrolizumab and M032 (NSC 733972)

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaGliosarcoma
University of Alabama at Birmingham 28
Early research (Phase 1)Looking for participantsNCT07733674
What this trial is testing

Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Glioblastoma Multiforme (GBM)Pancreatic Ductal Adenocarcinoma (PDAC)
Radiomedix, Inc. 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05664243
What this trial is testing

A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
In8bio Inc. 4
Large-scale testing (Phase 3)Looking for participantsNCT03970447
What this trial is testing

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Global Coalition for Adaptive Research 2,250
Early research (Phase 1)Active Not RecruitingNCT04477200
What this trial is testing

Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma

Who this might be right for
Recurrent GlioblastomaRecurrent GliosarcomaRecurrent Astrocytoma, Grade IV+3 more
University of Michigan Rogel Cancer Center 68
Early research (Phase 1)Study completedNCT00004212
What this trial is testing

DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas

Who this might be right for
Brain and Central Nervous System TumorsLymphomaUnspecified Childhood Solid Tumor, Protocol Specific
Daiichi Sankyo
Early research (Phase 1)Looking for participantsNCT04732065
What this trial is testing

ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors

Who this might be right for
Diffuse Midline Glioma (DMG)GlioblastomaRecurrent Ependymoma+5 more
Sabine Mueller, MD, PhD 208
Testing effectiveness (Phase 2)Study completedNCT00002752
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers

Who this might be right for
Brain and Central Nervous System TumorsMetastatic Cancer
Duke University
Large-scale testing (Phase 3)Ended earlyNCT01132547
What this trial is testing

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

Who this might be right for
Cancer
University of South Florida 22
Very early researchActive Not RecruitingNCT05076513
What this trial is testing

Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma

Who this might be right for
GlioblastomaGlioblastoma MultiformeGlioma+3 more
Nader Sanai 42
Not applicableStudy completedNCT03194971
What this trial is testing

NovoTTF Treatment Signatures in Glioblastoma Patients at Autopsy

Who this might be right for
Glioblastoma
Medical College of Wisconsin 20
Large-scale testing (Phase 3)UnknownNCT00003788
What this trial is testing

Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Colorado Health Foundation 270
Testing effectiveness (Phase 2)WithdrawnNCT01445691
What this trial is testing

More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery

Who this might be right for
Benign Neoplasms, BrainBrain CancerBrain Neoplasms, Benign+12 more
Constantinos Hadjipanayis
Next Page